跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zynasalo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zynasalo
Approved
STANDARD
Zynasalo
EBE PHARMACEUTICAL CO., LTD.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
de015c507c29fdc2
Company
EBE PHARMACEUTICAL CO., LTD.
Type
Standard
Approval Details
Approval Id
de015c507c29fdc2
Drug Approval Philippines Name
Zynasalo
Product Name
Zynasalo
Registration Number
DRP-14213
Brand Name
Zynasalo
Generic Name
Xylometazoline (as Hydrochloride)
Dosage Form
Nasal Spray
Dosage Strength
500 mcg/mL (0.05 % w/v)
Manufacturer
EBE PHARMACEUTICAL CO., LTD.
Importer
Aglobal Care, Inc.
Distributor
Aglobal Care, Inc.
Issuance Date
27 July 2023
Expiry Date
27 July 2028
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
de015c507c29fdc2
Type
Standard
Back to Philippines FDA Approvals